Literature DB >> 2853079

Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model.

A Müller1, F Machnik, T Zimmermann, H Schubert.   

Abstract

Long term administration of thioacetamide (0.03% in tap water) results in a characteristic lesion in rat liver, which corresponds to cirrhosis-like patterns of micronodular cirrhosis type after treatment over 3 months. During its development a reproducible temporal course of biochemical and morphological changes can be recognized. After withdrawal of the toxic agent this lesion persists for about 2 months. Then the cirrhosis-like alterations recede and a proliferation of bile ducts predominates, which is associated with increasing portal fibrosis altering the pattern and relatively enhancing the total collagen content of the liver. Considering these peculiarities, the TAA-model is suitable for investigations into connective tissue metabolism in the fibrotic liver and cirrhosis-like patterns. Search for and test of therapeutic principles should be done during TAA-administration (prophylactic agents) or within 2 months after withdrawal of toxic agents (therapeutics).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853079     DOI: 10.1016/s0232-1513(88)80155-5

Source DB:  PubMed          Journal:  Exp Pathol        ISSN: 0232-1513


  42 in total

1.  Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis.

Authors:  Vyacheslav U Buko; Oxana Y Lukivskaya; Elena E Naruta; Elena B Belonovskaya; Horst-Dietmar Tauschel
Journal:  J Clin Exp Hepatol       Date:  2014-02-21

2.  Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues.

Authors:  Leah M Norona; Deborah G Nguyen; David A Gerber; Sharon C Presnell; Edward L LeCluyse
Journal:  Toxicol Sci       Date:  2016-09-07       Impact factor: 4.849

Review 3.  The balancing act of the liver: tissue regeneration versus fibrosis.

Authors:  Lucía Cordero-Espinoza; Meritxell Huch
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

4.  Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury.

Authors:  Sabrina Fan; Ching-Feng Weng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

5.  qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.

Authors:  Shuoyu Xu; Yan Wang; Dean C S Tai; Shi Wang; Chee Leong Cheng; Qiwen Peng; Jie Yan; Yongpeng Chen; Jian Sun; Xieer Liang; Youfu Zhu; Jagath C Rajapakse; Roy E Welsch; Peter T C So; Aileen Wee; Jinlin Hou; Hanry Yu
Journal:  J Hepatol       Date:  2014-02-26       Impact factor: 25.083

Review 6.  Role of the blood coagulation cascade in hepatic fibrosis.

Authors:  Asmita Pant; Anna K Kopec; James P Luyendyk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-03       Impact factor: 4.052

7.  Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and Schistosomal infection in mice.

Authors:  Mohamed H Hessien; Ismaiel M El-Sharkawi; Ahmed A El-Barbary; Doha M El-Beltagy; Ned Snyder
Journal:  BMC Gastroenterol       Date:  2010-06-01       Impact factor: 3.067

8.  The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat.

Authors:  Kum Fai Chooi; Dinesh Babu Kuppan Rajendran; Siew Siang Gary Phang; Han Hui Alden Toh
Journal:  J Vis Exp       Date:  2016-06-17       Impact factor: 1.355

9.  Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat.

Authors:  Georgios Gribilas; Apostolos Zarros; Athina Zira; Costas Giaginis; Gerasimos Tsourouflis; Charis Liapi; Chara Spiliopoulou; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2008-12-10       Impact factor: 3.199

10.  Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo.

Authors:  Feng Hong; Hsini Chou; Maria Isabel Fiel; Scott L Friedman
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.